Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Sleep Initiation and Maintenance Disorders: HELP
Articles by Anonymous230788
Based on 1 article published since 2009
(Why 1 article?)
||||

Between 2009 and 2019, Anonymous230788 wrote the following article about Sleep Initiation and Maintenance Disorders.
 
+ Citations + Abstracts
1 Guideline [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly]. 2014

Medina-Chávez, Juan Humberto / Fuentes-Alexandro, Salvador Amadeo / Gil-Palafox, Irwin Bernardo / Adame-Galván, Lorena / Solís-Lam, Fernando / Sánchez-Herrera, Lucía Yveth / Sánchez-Narváez, Francisco / Anonymous230788. ·División de Excelencia Clínica, Coordinación de Unidades Médicas de Alta Especialidad, Instituto Mexicano del Seguro Social, Distrito Federal, México. humberto.medina@imss.gob.mx. ·Rev Med Inst Mex Seguro Soc · Pubmed #24625494.

ABSTRACT: Insomnia is the difficulty to initiate or to maintain sleep. It also has to do with waking up too early at least for a month. A patient with insomnia has daytime consequences such as fatigue, sleepiness, changes in mood, lose of concentration, as well as changes in his social performance and his family relationships, among others. The relationship between this disorder and physical and mental health is important due to the impact that it has on the quality of life and life expectancy of those who suffer from it. Unfortunately, insomnia usually goes unnoticed or untreated, which contributes to the onset or worsening of psychiatric and medical conditions. This exacerbates the problem of insomnia in the elderly people. In relation to the treatment it is recommended: 1) the search and management of secondary causes of insomnia, 2) a non-drug therapy that includes sleep hygiene measures, 3) pharmacotherapy. It is not recommended to start a treatment with a hypnotic drug without rule out medications or diseases that cause or exacerbate insomnia. It is not recommended the use of narcoleptics, melatonin, antihistamines or long half-life benzodiazepines. The consequences include limitations on activities of daily living, loss of functionality, impaired quality of life, increased morbidity and mortality, as well as the worsening of preexisting chronic conditions.